Trauma Resilience and Recovery Program for PTSD
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
The Trauma Resilience and Recovery Program (TRRP) has shown high engagement rates in trauma centers, indicating its potential effectiveness in addressing PTSD and depression after traumatic injuries. Additionally, similar programs like the PTSD Recovery Program have been effective in reducing PTSD symptoms in different populations, such as refugees, suggesting that TRRP may also be beneficial.
12345The Trauma Resilience and Recovery Program (TRRP) is unique because it is a technology-enhanced model that combines education, screening, and service referrals to address PTSD and depression after traumatic injury, focusing on high engagement even in resource-limited settings. Unlike traditional cognitive therapies, it uses a 'bottom-up' approach, emphasizing sensory awareness for emotion regulation, which may be more effective for trauma recovery.
34567Eligibility Criteria
This trial is for English or Spanish speakers aged 16+ who are admitted to George Washington University's trauma center and show a risk for PTSD or depression after injury. Exclusions include severe brain injuries, cognitive impairments, psychosis, inability to communicate verbally, or serious substance abuse.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Intervention
Participants receive education at the bedside about mental health recovery after traumatic injury, risk assessment, and brief intervention for high-risk patients
Symptom Monitoring and Education
Participants engage in symptom self-monitoring and continued education via an automated text messaging system
PTSD and Depression Screening
Screening for PTSD and depression by chatbot or telephone 30 days post-injury
Referral and Handoff
Referral and warm handoff to mental health services if needed
Follow-up
Participants are monitored for clinical and functional outcomes at 3-, 6-, and 12-months post-baseline